In tumor cells and macrophages, TPM4 expression showed an increasing trend as the WHO grade increased, suggesting that TPM4 abnormality was mainly attributed to tumor progression and tumor-associated macrophage (TAM) infiltration, which was further confirmed in the subsequent pseudotime trajectory analysis. The gene discussed is TPM4; the disease is neoplasm.